Then we adopted the primary MYLIP mRNA expression data (log2) in breast cancer samples and adjacent normal breast tissues from the TCGA database, and found that the expression level of MYLIP was significantly down-regulated in breast cancer samples compared with normal breast tissues (***p < 0.001) (Figure 1B, Supplementary Figure 1B). This evidence concerns the gene MYLIP and breast carcinoma.